entertainment -WSS

entertainment

author：knowledge 2025-10-02 11:09:27 - browse：2

Biogen, a biotech giant plagued by years of boardroom strife, said late Monday that the longtime and polarizing director Alex Denner would step down from its board, sending a signal to investors that the company’s fractious recent history might be coming to a close.

What Biogen didn’t disclose is that its nominee to replace Denner on the board, Susan Langer, is Denner’s live-in romantic partner and the mother of his child, born in November, according to court records obtained by STAT. Denner is in the middle of a protracted divorce from his wife of nearly 25 years, with whom he has two teenage sons — a bitter legal fight in which his extramarital relationship with Langer is a contentious issue, according to the records.

Biogen spokesperson Jack Cox said the company knew about the relationship between Denner and Langer. He also said that Denner recommended Langer to Biogen’s board — he said he incorrectly stated at first that Denner nominated her — but declined to comment on the company’s vetting process and whether it planned to disclose the relationship to shareholders before they vote on Langer’s candidacy later this month. Biogen also omitted mention of the relationship from Langer’s biography in a Securities and Exchange Commission filing Tuesday morning.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Biotech execs pursue obesity drug boom: ‘It’s the early innings’

WSS

AstraZeneca chief proposes a novel edit to the drug pricing bill

15 die by electrocution after transformer explodes in northern India

How generative AI is inspiring dreams of a health data revolution

Study: Hearing aids may slow cognitive decline in those at risk

What we know about the American soldier detained in North Korea

Illumina names Agilent executive as new CEO

entertainment

entertainment

focus

Hepatitis C has a cure — but many Americans still lack access to it

The (many) problems with a new study criticizing cancer screening

Bright Health sells Medicare Advantage business to Molina

A rare thyroid diagnosis led to unexpected, all

Anesthesiologist group: stop taking Ozempic before surgery

House passes resolution saying Israel isn't a 'racist or apartheid state'

Psychedelics group wrestles with new pharma identity

Seth Rogen and Lauren Miller Rogen on Alzheimer's caregiving

Wildfire smoke exposes gaps in outdoor worker protections

US soldier in North Korean custody after crossing DMZ line

hotspot

Robert Kennedy Jr.'s presidential campaign attracts GOP

ALS advocates say criticism of new drugs misses bigger picture

Amazon on where the company's health care bets are headed next

Snackable artificial intelligence, expert AI, and the pharma industry

Amazon on where the company's health care bets are headed next

Study: Hearing aids may slow cognitive decline in those at risk

explore

focus

hotspot

entertainment